1762 — Chunghwa Chemical Synthesis & Biotech Co Cashflow Statement
0.000.00%
Last trade - 00:00
- TWD3.30bn
- TWD4.09bn
- TWD2.09bn
- 50
- 38
- 32
- 31
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 144 | 650 | 498 | 583 | 333 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -16.7 | -385 | -31.9 | -73.1 | -36.1 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 11.4 | -259 | -379 | 54.6 | -557 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 268 | 138 | 219 | 734 | -66.3 |
Capital Expenditures | -115 | -193 | -405 | -376 | -452 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -154 | 1,058 | -397 | 0 | -9.77 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -269 | 865 | -803 | -376 | -461 |
Financing Cash Flow Items | -0.126 | -0.14 | -0.333 | -0.279 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3.5 | -955 | 631 | -253 | 497 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -5.15 | 47.4 | 46.6 | 105 | -31 |